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Vaults are the largest known cytoplasmic ribonucleoprotein structures and may function in innate immunity. The vault
shell self-assembles from 96 copies of major vault protein and encapsulates two other proteins and a small RNA. We
crystallized rat liver vaults and several recombinant vaults, all among the largest non-icosahedral particles to have
been crystallized. The best crystals thus far were formed from empty vaults built from a cysteine-tag construct of major
vault protein (termed cpMVP vaults), diffracting to about 9-A˚ resolution. The asymmetric unit contains a half vault of
molecular mass 4.65 MDa. X-ray phasing was initiated by molecular replacement, using density from cryo-electron
microscopy (cryo-EM). Phases were improved by density modification, including concentric 24- and 48-fold rotational
symmetry averaging. From this, the continuous cryo-EM electron density separated into domain-like blocks. A draft
atomic model of cpMVP was fit to this improved density from 15 domain models. Three domains were adapted from a
nuclear magnetic resonance substructure. Nine domain models originated in ab initio tertiary structure prediction.
Three C-terminal domains were built by fitting poly-alanine to the electron density. Locations of loops in this model
provide sites to test vault functions and to exploit vaults as nanocapsules.
Citation: Anderson DH, Kickhoefer VA, Sievers SA, Rome LH, Eisenberg D (2007) Draft crystal structure of the vault shell at 9-A˚ resolution. PLoS Biol 5(11): e318. doi:10.1371/
journal.pbio.0050318
Introduction
Vault ribonucleoprotein particles are found in the cyto-
plasm of most eukaryotic cells [1]. Ninety-six copies of major
vault protein (MVP; 95.8 kDa) form the thin, hollow vault
shell with dimensions reported as 7253 4103 410 A˚3 [2]. The
MVP shell encapsulates a 50 3 106–A˚3 interior volume that
contains 2–4 copies of telomerase associated protein 1 (TEP1;
290 kDa), about 12 copies of an enzyme, poly(ADP-ribose)-
polymerase (VPARP; 193 kDa), and 8–16 copies of a small
untranslated RNA. The mass of a rat liver vault is about 133
106 Da [3]. Most eukaryotic cells contain upwards of 10,000
copies of vaults [4]. MVP expressed in insect cells self-
assembles into vault shells [5].
Vaults were recently shown to have a protective role in
innate immunity [6]. MVP co-localized with Pseudomonas
aeruginosa in lung epithelial cells at an early stage of
infection, and MVP knockout mice [7], which do not form
vault particles, were shown to be more susceptible to
bacterial lung infection. Vaults had previously been impli-
cated in multidrug resistance [8] and cellular signaling [9–12];
however, their exact role in any of these pathways remains
elusive.
Vault structure has previously been probed by trans-
mission electron microscopy, cryo-electron microscopy (cryo-
EM), and nuclear magnetic resonance (NMR). Multi-image
averaging greatly clarified the cryo-EM image of the MVP
shell [1]. Vault anatomical terms, emerging from both earlier
work and our own, are shown in Figure 1. Internal contents
of rat vaults and new features of modified recombinant vaults
have been localized by cryo-EM difference mapping. The
RNA and a portion of TEP1 reside inside the vault near the
ends of its two caps [13]. The N termini of MVP form the
waist and extend toward the vault interior, and VPARP
localizes onto the inner surfaces of the vault [2]. During our
work, an MVP substructure was determined by NMR
(residues 113–221 of human MVP [14]). Engineering of the
vault by encapsulation of exogenous components has begun
[15]; proteins can be targeted to the inside surface of the
vault by expression as fusions with either the N terminus of
MVP or a VPARP-derived targeting domain, and localization
to the vault interior can be confirmed by cryo-EM difference
mapping.
Extending the cryo-EM vault structure via crystallography
to derive an atomic model is of great potential value in
designing modifications of the vault structure and to
elucidate function. The crystallographic difference-Fourier
technique applied to future cocrystals could precisely localize
internal vault components, while indicating their shapes and
thus orientations relative to the MVP shell.
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Results
Initial Phasing of x-Ray Reflections and Evidence of
Domains
Phasing was initiated by manual placement of cryo-EM
electron density of a half vault at a crystal 2-fold axis (see
Methods). The phases, and thus the detail in the image of the
vault, were initially improved by density modification using a
single 48-fold rotational noncrystallographic symmetry (NCS)
operator (marked NCS in Figure 1). NCS is symmetry of the
vault that is not shared with the crystal. The results from
testing parameters for averaging paralleled those reported
for spherical viruses [16,17], except that the phases ‘‘con-
densed’’ into two pseudo-Babinet-inverse sets (see Methods
and Figure S1). One phase set was selected because the map
derived from it contained double-disk C-terminal structures
that could plausibly contain 24-fold symmetric MVP chains in
each layer (marked 24C in Figure 1).
The featureless cryo-EM electron density separated into
globules in the more plausible 48-fold averaged electron
density map (Figure 2), indicating more preferential cohesion
within short segments of the MVP chain than between
consecutive segments. This meant that the MVP monomer,
at least below the C-terminal cap structure, folded into
domains (see Figure 1 for initial partitions). The first
averaging was not biased by prior expectation of domains.
The density globules were spaced as would be backbone
atoms with side chains between. The barrel portion of the
vault appeared built from vertical ‘‘staves’’ of stacked
domains. Observation of stacked domains parallels one
conclusion of the NMR spectroscopists [14].
This initial 48-fold averaging was later improved by ‘‘dot
model refinement,’’ applying concentric 24-fold (density
block 11 in Figure 1) and 48-fold (density blocks 1–10 in
Figure 1) NCS axes (see Methods) and domain-shaped ‘‘dot
Figure 1. Thin Section of Crystalline Vault Electron Density
The red lines show the crystal x and z directions, and the direction of the high-symmetry vault axis (marked NCS for noncrystallographic symmetry). The
two neighboring vaults at upper right and lower left are related to the central vault by translations along the crystal z direction. The vault and the map
are centered at (0,0,0) (contoured box is 530 A˚ along the crystal x-axis, 5-A˚ thick on y, and 845 A˚ along z). Regions of the vault discussed in the text are
labeled at lower right. The vault model is 675 A˚ tip-to-tip and 417 A˚ in diameter at the widest part of the barrel. The 96 N termini are inside the vault at
the waist region (marked 48N). Pairs of MVP chains become nonequivalent in the crossover zone as they approach the double-layer, C-terminal disk
regions (C termini of the model are marked 24C). The vault model leaves ;29-A˚ holes between C termini. The green lines at upper left mark the
partitions between density blocks 1–11 used for ‘‘dot model refinement.’’ These partitions were chosen for convenience of handling files and do not
match the cpMVP model domains (Table 1 and Figure 4). The blue numbers at upper left are density block size estimates: (873 residues)3 (dots in
block)/(total dots). The block size estimates were used for initial placement of cpMVP model domain 7. This figure, including the red and green lines,
was made with XFIT of XtalView [40] and RENDER of Raster3D [44], and was labeled with Adobe Photoshop.
doi:10.1371/journal.pbio.0050318.g001
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Author Summary
Vaults are large barrel-shaped particles found in the cytoplasm in all
mammalian cells, which may function in innate immunity. As
naturally occurring nanoscale capsules, vaults may be useful objects
to engineer as delivery vehicles. In this study, we propose an atomic
structure for the thin outer shell of the vault. Using x-ray diffraction
and computer modeling, we have inferred a draft atomic model for
the major vault protein, which forms the shell-like enclosure of the
vault. The shell is made up of 96 identical protein chains, each of 873
amino acid residues, folded into 14 domains. Each chain forms an
elongated stave of half the vault, as well as the cap of the barrel-like
shell. Our draft atomic model is essentially an atomic-level model for
the entire 9.3-MDa vault shell, which offers a guide for protein
engineering to test vault functions and to exploit vault particles as
nanocapsules.
models’’ to re-initiate the phase sets. The enantiomer of the
electron density map was assigned during model building.
Construction of the Vault Model
Each half vault consists of 24 identical pairs of MVP chains
A and B. Chains A and B differ only near their C termini. The
unique parts of the cpMVP model (chain B and C terminus of
chain A) were built into the electron density map resulting
from ‘‘dot model refinement’’ (Figure 3). Because of non-
equivalence of the C termini, the unique part of the model
was assembled from 15 models of 14 domains. The stack of 15
domain models is shown in Figure 4 (see Table 1 for domain
partitions; see Methods for construction details and for
model validation). The cpMVP model contains 749 of the 873
residues expected for this construct, starting at residue 3T of
the N-terminal cysteine tag inside the vault waist, and ending
in nonequivalent residues 779 in the two C-terminal cap
disks. C-terminal residues 780–861 appear to be located
outside the vault, above the present model (VAK, LHR, and P.
Stewart, unpublished data).
The 15 domain models from three sources are shown as
panels of Figure 5. Domains 3, 4, and 5 were derived from the
NMR structure of domains 3 and 4 (Protein Data Bank (PDB)
[18,19] entry 1Y7X [14]). Domains 1, 2, and 6–12 originated in
models predicted with the ROSETTA algorithm [20–22]
operating on several MVP sequence segments (see Table 1
and Methods). Domain 13 and the nonequivalent C-terminal
domains 14a and 14b (see next section) were built by inserting
poly-alanine segments into density, then iteratively shifting
and modifying segments to pack the density with plausible
topology and backbone geometry. The MVP sequence was
applied to domains 13, 14a, and 14b when the other cpMVP
domain models were nearly complete. As discussed in the
Validation section of Methods, most domain models appear
correct by the available criteria: correlation of backbone to
density, plausibility of backbone geometry, and by estimation
of side-chain interactions.
The MVP structure in the ‘‘crossover zone’’ (Figures 1, 4,
and 5K) reduces the vault symmetry from 48-fold in the waist,
barrel, and cap helices (residues 3T–715) to 24-fold in the C-
terminal cap disks (residues 716–779). cpMVP model chains A
and B become nonequivalent in the crossover zone. Assuming
that identical sequences in chains A and B would result in
similar structures, the crossover model was built as short A
and B segments adjacent to approximate local 2-folds. The
model shown in Figure 5K, when repeated 24 times and
viewed at low resolution, would form the two electron density
rings in the crossover zone between the two symmetries. The
electron density in the two C-terminal cap disks indicated
Figure 2. Overall View of the cpMVP Vault Averaged Electron Density
Map, at about 9-A˚ Resolution, in the Context of the Crystal Packing
This electron density map (wire frame representation) resulted from
applying solvent flattening and a 48-fold rotational symmetry averaging
to the featureless cryo-EM electron density. Separation into globules of
density showed that the MVP chain folds into a series of domains. The
short red line is a 100-A˚ scale bar. The line marked NCS shows the
noncrystallographic symmetry axis used for phasing. One of the 48 2-fold
axes through the vault waist is coincident with the crystal 2-fold in the y
direction (perpendicular to NCS axis). The figure was made using XFIT of
XtalView and RENDER of Raster3D, then labeled with Adobe Photoshop.
A section through the top of this figure is part of Figure S1.
doi:10.1371/journal.pbio.0050318.g002
Figure 3. Overall View of Dot-Refined Vault Electron Density with the
Unique Parts of the cpMVP Model Inserted
One copy of the cpMVP model is shown as red atoms, from its N
terminus at the waist to the crossover zone near the top (as in Figure 4).
Two nonequivalent copies of cpMVP model are shown from the
crossover to the C termini (the path of the green cpMVP model is
mostly occluded; see Figure 1 for orientation). The electron density map
coefficients were Fobserved, and the phase set was the enantiomer of the
phases from the slow-averaged Dot Model 6. The contour level was 1.2r.
The electron density becomes less symmetric near crystal lattice contacts
(left of center, foreground). The map and masks were produced with
CCP4 programs [31]. Surrounding electron density was masked off to
make this figure. The density around the cpMVP model was deleted with
an inverse mask (inversion performed with MAMA [45]). The opaque iso-
surface representation with ‘‘fog’’ representing distance was drawn with
PyMOL [46].
doi:10.1371/journal.pbio.0050318.g003
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that the pairs of MVP chains enter the disks in opposite
directions (Figure 5L). Reasoning as above, the C-terminal
cap disk models were built upside down relative to each
other. The asymmetric unit of the vault is thus a dimer of
MVP molecules (model chains A and B). To complete the AB
dimer model from the unique parts of the cpMVP model
(Figure 4), chain B residues 3T–715 were rotated by one
leftward increment of 48-fold NCS rotation to produce chain
A residues 3T–715.
The asymmetric unit of the vault crystal is a half vault built
by 24-fold NCS rotation of the AB dimer (blue-red pair in
Figure 6A). The 417- 3 417- 3 675-A˚3 whole-vault model
(Figure 6B; fills density of Figure 3) is generated from the
half-vault model by 2-fold rotation around the crystal y-axis
(bottom of Figure 6A). The whole-vault model may be
reconstructed from the cpMVP dimer model and rotation
matrices contained in PDB entry 2QZV. Because the full
model in Figure 6B (96 copies of 749 residues) is cumbersome
to examine, a partially assembled cpMVP model is provided
as Model S1.
Discussion
The Draft Model of the Vault Shell
Building an atomic model into 9-A˚ electron density
represents crystallography at the edge of what is possible.
Model building could only be attempted because the
locations of the N and C termini had already been established
by cryo-EM, and because the electron density of the vault
shell is very thin. The ‘‘petal’’ shapes of collapsed vaults [3]
indicated that the MVP domains stack vertically, thus limiting
the volume of density to consider for each domain. That is,
the sharp edges of the ‘‘petals’’ limit lateral excursions of the
polypeptide chain, supporting the quasi-linear spoke struc-
ture that we find for MVP in the vault. In building the model,
we assigned model shapes of domains into electron density
shapes, resulting in what we term a draft model. We recognize
the substantial uncertainties in this model, and discuss them
in Text S1.
The construction of the draft model is motivated by two
goals. The first is to lay a basis for further x-ray crystal studies
of vaults. The next steps are crystal improvement of the vault
shell and crystallization of substructures, partitioned at
domain boundaries derived from our current model and
sequence analysis. The substructures can be inserted into
density derived from crystallography of the whole vault, as
has been done for cryo-EM density of other large structures
Figure 4. The Unique Parts of the cpMVP Model, in Two Overall Views
The current cpMVP model contains 749 of the expected 873 cpMVP
residues. The model is represented by ribbons. In the right part of the
figure, the cpMVP model is oriented to resemble the cross-section
shapes in Figures 1, S4, S5, and S6. The arrow at far right shows the
approximate view direction for the left part of the figure. In the left view
of the model, the symmetry-averaging direction is left-right (NCS axis is
vertical, behind the page; direction of rotation around the NCS axis is
marked NCS). Domain colors alternate (red-green-blue), with color
transitions at residue numbers listed in Table 1. The colored domain
numbers in the right part of the figure mark the domains and also show
approximate viewpoints for Figure 5 (except domain 11). Both views of
the model show one cpMVP chain (chain B) from the N-terminal residue
Gly 3T to residue 715 just under the crossover zone of domains 14a and
14b. At the crossover (Figure 5k), the 48-fold symmetry transitions to 24-
fold. Two cpMVP chains (chains A and B) are shown on their
nonequivalent paths from the crossover to the C termini of domains
14a and 14b (two residue 7799s marked C). The cpMVP dimer model
(PDB entry 2QZV) was completed from the unique model shown here by
rotation of chain B residues 3T to 715 by one leftward increment of 48-
fold NCS rotation. The cpMVP dimer model is 354 A˚ and 368 A˚ from the
N termini to their corresponding inner and outer C termini. The residue
numbers and locations in this model will help identify trial modification
sites for engineered vaults. The two figure components were made with
PyMOL [46], then combined and labeled with Adobe Photoshop.
doi:10.1371/journal.pbio.0050318.g004
Table 1. Domain Partitions
Domain Residue
Ranges
Working
Models
Origins of
Starting
Models
1 3T–22 3T–21 ROSETTA 4–54 and
Handbuilt 3T–3
2 23–101 22–87 and 88–101 ROSETTA 1–87 and
88–112
3 113–165 113–166 NMR 1Y7X (14)
4 166–219 167–221 NMR 1Y7X (14)
5 220–276 222–276 Threaded onto
Domain 4
6 306–357 306–356 ROSETTA 306–357
7 358–404 357–404 ROSETTA 357–404
8 405–447 405–444 ROSETTA 405–465
9 448 to about 492 445–500 ROSETTA 405–532
10 about 493 to
about 562
501–550 ROSETTA 500–550
11 about 563 to 599 551–600 ROSETTA 521–600
12 600–642 601–640 ROSETTA 580–640
13 643–718 641–715 Handbuilt
14a 719–779 716–779 Handbuilt
14b 719–779 716–779 Handbuilt
The residue ranges of domains were assigned as best as possible by examination of the
cpMVP model built by concatenation of working models. Subsets of some ROSETTA
starting models were used as working models for manual fitting to density.
doi:10.1371/journal.pbio.0050318.t001
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[23–25]. Such a cloning, expression, and crystallization effort
could be hindered by the side-to-side interactions that build
the vault (Figure 6), but these could be alleviated by residue
replacements at the interaction points. The second reason to
build the draft model is to guide projects of vault engineer-
ing, discussed in the following section.
Vault Engineering
Identifying or engineering a specific property, such as
metal binding, would require reasonably accurate juxtaposi-
tion of ligand atoms. We have tentatively identified some
candidate metal-binding sites by the simplistic means of
searching for adjacent aspartate and glutamate residues. At
the local 2-fold axes between N-terminal domains (yellow bars
in Figure 5A), Glu 4 and Glu 5 face Glu 4 and Glu 5 of the
nonequivalent MVP in the other vault half, backed by two
copies of Met 1 side chains [26]. Asp 20 in one vault half faces
Asp 20 in the equivalent chain in the other vault half (across
the black 2-fold bars in Figure 5A). Metal affinity at the N
termini is consistent with observation of acid dissociation of
vault halves [27]. The model of domain 12 (Figure 5I) reaches
left to nearly bring together Asp 615 and Asp 566 (or possibly
Asp 570) in domain 11 from two positions left. Thus these
aspartates may be a metal affinity site.
The draft model offers ideas about the binding sites for the
other vault components. Charge clusters could signify affinity
sites for internal vault components. Negative charges
clustered by sequence adjacency were found on the inside
surface of the vault at domain 6 (Glu 342, Glu 344, Glu 346,
and Glu 347). Positive charges clustered by the fold were
found on the inside surface of the vault at domain 10 (Lys
506, Arg 507, His 509, Arg 511, and Arg 512). Residues 102–
112 and 277–305 could not be placed in density. The site that
277–305 would occupy is slightly above the location indicated
by cryo-EM analysis as the site with most binding energy for
the MVP interaction domain of VPARP [15]. Atoms of 277–
305 could become ordered on contact with VPARP, and this
loop could be a target for insertion of a binding motif in an
engineered vault.
The draft model provides a list of sequence positions likely
to be loop structures where ligand-binding sequences may be
inserted. Passenger proteins could then be targeted to the
vault interior or exterior (analogous to [15]). The estimated
domain boundaries and preliminary model may be useful for
further fold predictions and fold recognitions.
Vault Function
The draft model of the vault shell offers new conjectures
about vault function. It has been suggested that vaults may
interact with lipid rafts [6]. A bulk property, such as
membrane binding, would be enhanced by the geometric
repeating vault structure. In domains 3, 4, and 5 (as currently
folded), side chains of Trp 143, Trp 196, and Trp 249 are
located on an almost straight vertical line (Figure 5C). The
left-right rotational repeat generates a geometric belt of
membrane anchor residues around the vault barrel. The
cascading energy of immersing triples of Trp side chains in a
membrane could be enough to bend the membrane, or to
initiate a vertical split in the vault barrel. A split vault could
better contact the membrane, and could release vault
contents.
An amphiphilic crevice that could bind lipid was found at
the top of the vault shoulder. The inner surface of the crevice
(Figure 5H) is formed by the top of domain 10, surfaces of left
Figure 5. CpMVP Domain Models
The cpMVP chains are shown in ribbon representation. Except as noted, chain A (leading to outer C terminus) is blue. NCS-related type A chains are
cyan. Chain B (leading to inner C terminus) is red. NCS-related type B chains are pink. Residues discussed in the text are green. The Fobserved electron
density map is displayed as wire frame on a 2.6-A˚ grid. Except as noted, the viewpoints for these figures are at the approximate locations of the colored
numbers in Figure 4, and ‘‘up,’’ ‘‘down,’’ ‘‘left,’’ ‘‘right’’ refer to the left part of Figure 4.
(A) Domain 1. The viewpoint is at the red ‘‘1’’ in the right part of Figure 4, looking down and left from that point (into the paper). The N-terminal
domains at the vault waist nestle between local (yellow) and global (black) 2-folds. Type A chains (outer C termini) are blue (top half vault) and cyan
(bottom half vault). Type B chains (inner C termini) are red (top half) and pink (bottom half). The cysteines at the yellow local 2-folds disulfide bridge
nonequivalent cpMVP chains in the upper and lower vault halves. Green residues are Glu 4, Glu 5, and Asp 20. Domains in the top and bottom vault
halves are staggered, not stacked (see Figure 6B).
(B) Domain 2.
(C) Domains 3, 4, and 5, derived from the NMR substructure (PDB entry 1Y7X). The density shape nearly repeats in these domains. Green residues are
tryptophans 143, 196, and 249.
(D) Domain 6.
(E) Domain 7. The viewpoint is at the red ‘‘7’’ in Figure 4, looking left (out of the paper). Green residues are prolines 367 and 381.
(F) Domains 8 and 9. Green residues are prolines 420, 445, and 448.
(G) Domain 10. The figure also shows three copies of part of domain 9 (yellow ribbon in background) and three copies of about half of domain 11 (gray
helix at top).
(H) Domain 11. The viewpoint is at the blue ‘‘12’’ in Figure 4, looking down. Domain 12 has been removed from the foreground. Three copies of domain
10 are shown as yellow ribbon in the background. The volume enclosed by two copies of domain 11, domain 10 underneath, and domain 12 above
could be a lipid binding site.
(I) Domain 12. The helical domain 11, and parts of domains 10 (yellow, bottom) and 13 (gray, top) are also shown. The type A chain at far right (cyan)
reaches across domain 11 of chain B (red) towards a contact with chain A (blue) from two positions left. Similarly, chain B reaches across chain A to
contact a type B chain (pink) two positions left. Green residues are aspartates 566, 570, and 615.
(J) Domain 13. The alternating type A/type B pattern repeats left-right from what is shown. Green residues are Pro 645 (bottom) and Ala-Ala-Ala 671–
673 (below center).
(K) Crossover portion of domains 14a and 14b. The viewpoint is approximately at the ‘‘D’’ of the word ‘‘Double’’ in Figure 4. The crossover model
reduces symmetry from 48-fold (up to residue 715), to 24-fold (residues 716 to 779). At the top of this figure, the density (at higher contour) indicated
that the nonequivalent MVP chains enter the C-terminal disks in opposite directions. The upper and lower C-terminal disk models were built upside
down relative to each other. Green residues are Ser 718 (bottom), Gly 720 (lower ring), and Gly 737 (center).
(L) C-terminal cap disk portion of domains 14a and 14b. The view point is approximately at the ‘‘14a’’ mark in Figure 4, with the crossover zones at
bottom. Each outer C-terminal type A chain (blue and cyan) contacts an upside down type B chain to its left, and crosses over four type B chains to its
right. Each inner C-terminal type B chain (red and pink) contacts a type A chain to its right, and crosses underneath four type A chains to its left. Each
panel was made with PyMOL.
doi:10.1371/journal.pbio.0050318.g005
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and right copies of domain 11, and the bottom of domain 12
(Figure 5I). The electron density for domain 12 indicates
disorder, suggesting that its beta-sheet could be mobile.
The draft model hints at the origin of the striking eight-
petal geometry of the collapsed vault structure [3]. How do 24
identical MVP dimers of the half vault break apart into eight
identical petals? The answer may be at the top of the shoulder
region. Domain 12 of each cpMVP chain overhangs two
copies of domain 11 to tie together groups of three cpMVP
molecules (see left panel of Figure 4 and top of shoulder in
Figure 5I). This is at the base of the coiled-coil region
previously thought to stabilize the vault [28]. Vaults may thus
collapse into eight petals of six chains each (see Figure 9 of
[3]) in part because the MVPs are tied together as threes at the
top of the shoulder but twos in the barrel region.
An MVP C-terminal structure very similar to the non-
equivalent C termini of this model (top of Figure 4, and
Figure 5L) could be responsible for previous observations of
TEP1 density [29]. The model contains two C-terminal disks
built upside down relative to each other. According to this
model, if TEP1 and its RNA localize to the internal surface of
the inner disk, they would find similar contacts on the
exterior of the outer disk. Cryo-EM analysis of various
recombinant vaults containing the cpMVP construct used in
this study were unable to identify a TEP1 site for lack of
strong difference density [2]. However, as there are thought
to be only 1–2 copies of TEP1 per vault half, it may be
difficult to assign density to TEP1 in the absence of a higher-
resolution structure.
These few examples of new insights into vault engineering
and vault function demonstrate the potential usefulness of
the draft model of the vault shell described in this paper.
Figure 6. Assembly of the cpMVP Vault Shell Model
(A) The asymmetric unit of the crystal contains a half vault. This half-vault model was assembled from the cpMVP dimer model (one red-blue pair) by 24-
fold NCS rotation (axis marked NCS in Figures 1 and 2). The blue ribbons are type A chains (outer C termini). The red ribbons are type B chains (inner C
termini). The whole vault (B) is generated from the half vault by the 2-fold rotation axis along the crystal y direction adjacent to the N termini at the
bottom of this figure (see also Figure 5a). The many contacts between adjacent cpMVP chains may be seen in the interdigitating shapes of the domains.
This figure was made with PyMOL, labeled with Photoshop.
(B) Whole-vault model. The whole-vault model (48 cpMVP dimers) is 675 A˚ top to bottom, and 417 A˚ at the widest part of the barrel. A stack of blue
domains in the upper half vault is staggered between stacks of red and blue domains in the lower half-vault. The origin of this offset is shown in Figure
5a.
doi:10.1371/journal.pbio.0050318.g006
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Materials and Methods
Vaults. The vault construct most successful for crystallography
thus far was cpMVP (96 copies of 96.8 kDa; [2]). The N-terminal 12-
residue sequence of cpMVP (MAGCGCPCGCGA) originated in a
metal-binding motif of metallothionein. The rest of the sequence
(861 residues) is the same as the rat liver MVP sequence (GenBank
accession code Q62667 GI:47606697). The N-terminal tag was
intended for heavy metal binding to help determine phases and thus
the structure, but it instead forms disulfide links thought to rigidify
the cpMVP vault and improve diffraction. cpMVP vault particles were
purified as described elsewhere [5]. Further details are given in Text
S2.
Crystallization and data collection. Crystals were grown by
hanging-drop vapor diffusion. Separate reservoir and precipitant
solutions decoupled the initial and destination drop conditions and
were prepared as follows. The 1-ml reservoir solutions contained
0.64%–0.76% polyethylene glycol (PEG) 8000, 3% glycerol, 0.05 M Na
MOPS, pH 7, 0.044 M MgCl2, and 0.2% n-octyl-b-D-glucopyranoside
(b-OG). If a 1-mM dithiothreitol (DTT) solution was used instead of
water to keep the volumes constant, the reservoir DTT concentration
was about 0.8 mM. DTT seems to delay crystallization while
encouraging growth of the favored C2 crystal form. The glycerol
and detergent minimally affected crystallization, but they did
facilitate later cryoprotection and reduce surface tension around
the crystal. The volume of water (or 1 mM DTT) in the reservoir was
critical to set the destination vapor pressure; one pipet was calibrated
to deliver this volume. The precipitant solutions contained 0.27%–
0.33% PEG 8000, 1.5% glycerol, 0.025 M Na MOPS, pH 7, 0.02 M
MgCl2, and 0.1% b-OG. The total volumes were completed with water
(or with 1 mM DTT to final concentration 0.9 mM). The precipitant
mixtures were centrifuged at 10,000g for 3 min. The hanging drops
were made by mixing 1.5-ll vault and 3-ll precipitant solutions. The
air volume was initially saturated with cyclohexane (see Text S2 for
further details). Crystallizations were partially protected from room
vibrations by low-cost isolator platforms (Text S3). Crystals were
cryoprotected and annealed by floating microdialysis (Text S4 and
Figure S2). Diffraction data were collected at Advanced Light Source
Beamline 8.2.2. The x-ray beam was focused at detector position
(Text S5).
Initial phasing. Initial phases were generated by manually placing
half of the cryo-EM vault electron density in the crystal lattice at a 2-
fold as directed by the 13.688 b angle reported by the molecular
replacement rotation function. This is the same as the tilt away from
the orthogonal z-axis shown in the self-rotation function (Figure S3).
Automated molecular replacement had been abandoned due to the
inaccuracy of the translation function (see Text S6 and Figure S4).
The placement and artefactual thinning operations are shown in
Figure S5, and the packed phasing model is shown in Figure S6. The
positive-only half-vault density map from cryo-EM (prepared for
automated molecular replacement; Text S6) was scaled smaller (scale
factor 0.96 applied with MAPMAN [30]), masked by MAPMASK [31],
and the whole-vault center was translated to (0,0,0) with MAPROT
[31,32]. This simplified density modification (Text S7). The density
was re-masked at its new location, and the density was rotated13.688
around the y-axis (and thinned, Figure S5) with MAPROT. The
rotation function a and c angles both coincided with the vault high-
symmetry axis, and were ignored because the cryo-EM electron
density varied little around that rotation. Phases were calculated from
the density map (plus symmetry mates) with SFALL [31]. This initial
near-featureless phasing model was almost centrosymmetric [33].
Density modification. The phase set derived from the initial model
was improved by density modification by simultaneous application of
NCS averaging, solvent-flattening, and histogram matching, using DM
[31,34]. The cross-section in Figure 1 shows the relative locations of
the crystal and NCS axes. The center of symmetry was broken by
application of 48-fold NCS averaging (see Text S7; [33]). The
enantiomer was assigned later during model building. The phases
from the initial 48-fold average were further improved by iterative
‘‘dot model refinement’’ (Text S8), applying concentric 24- and 48-
fold averaging to phase sets initiated from models of unassigned
atoms (‘‘dots’’).
Validation of the phasing processes. Electron density features
revealed by crystallographic means could be indirectly validated (see
Text S8). The N-terminal disk inside the waist and the 48 holes at the
top of the shoulder were independently observed via cryo-EM [2]. The
globules of electron density (Figure 2) were spaced as though they
represented backbone atoms, separated by side chains. Some of the
predicted models (see below) and the NMR substructure [14]
resembled shapes at their corresponding electron density. In the
barrel region, a 3-fold repeat in the shape of the electron density
paralleled expectation of sequence repeats (Figure 5c). The accumu-
lated evidence indicated that the electron density was meaningful.
Sequence analysis and ab initio model building. The amino acid
sequence of MVP has yielded some useful structural expectations.
Using fold-prediction and fold-recognition algorithms, we sought
models to facilitate the interpretation of the electron density map.
To initiate tertiary structure prediction for the first 400 residues of
MVP, the sequence was divided at and near predicted domain
boundaries. The seven N-terminal MVP repeats as represented in the
PFAM protein domain database [35] were: residues 26–87, 88–141,
142–194, 195–247, 248–305, 306–355, and 356–404. For residues
thought to be in the vault shoulder (approximately residues 404–650),
several putative domain segments were created with sizes varying
from 40–80 residues. In this region, domain boundary selection was
first aided by prediction of loops using PSIPRED [36].
Ab initio models for each putative domain were generated with the
HMMSTR/ROSETTA web server [20–22]. The HMMSTR/ROSETTA
server divided the input sequence into short segments, searched a
database for plausible fragment structures, then attempted to
reassemble the fragments into a compact structure model, ignoring
the NCS neighbors. The server quickly returned results by using
shorter conformational searches with fewer repetitions than were
used in the original ROSETTA algorithm [37], and by performing ab
initio tertiary structure predictions on short segments of the chain,
which are subsequently combined with a genetic algorithm [21]. The
shapes and plausibilities of the ROSETTA models depended on the
choices of input residue windows. Thus, we used the simplified web
server version of ROSETTA for its speed in testing many residue
ranges. The sequence segments chosen to construct the cpMVP model
are listed in Table 1.
Both the HMMSTR/ROSETTA server and the 3-D-PSSM fold-
recognition server [38] predicted several beta-sheet–rich domains in
the N-terminal two-thirds of the MVP. The best 3-D-PSSM fold-
recognition matches in this region included the seven-bladed beta
propeller fold of Protein Data Bank (PDB; [18,19]) entry 2BBK, and
beta-sheet–rich structures 1BQS and 1NLT. These fold-recognition
matches did not fit well in the electron density. However, these
calculations suggested that the N-terminal region contains several
stacked beta-sheet–rich domains, in agreement with the observation
of strong reflection intensities at 10-A˚ resolution, and in agreement
with the NMR substructure [14].
We elaborated on the prior expectation of coiled-coil structure
[28] in the 650–800 region of the MVP sequence. Residues 570–600
and 650–825 were predicted to be mostly helical using the PSIPRED
secondary structure prediction method. Additionally, the 3-D-PSSM
fold-recognition server predicted that these regions match well with
long helices, such as those in PDB entries 1D7M, 1CUN, and 1KMI.
The gapped alignment with PDB entry 1D7M, for instance, has 30%
sequence identity to MVP residues 670–720 and 750–800. A high
probability of helical dimer or trimer in the range of residues 680–
750, was predicted using the MULTICOIL algorithm [39].
Construction of the cpMVP model. The cpMVP model was
assembled from 15 domain models, shown as panels in Figure 5,
and stacked in Figure 4. The origins and residue ranges of the
individual models are listed in Table 1. The model contains 749 of the
873 residues expected for the cpMVP construct. The domain models
were manually fit to a 9-A˚ resolution Fobserved map calculated with
enantiomer phases from slow reaveraging of Dot Model 6 (see Text
S8), using XFIT of XtalView [40]. The map was contoured at 1.2r and
2.6r on a 2.6-A˚ grid. The domain models (backbone and b-carbon
atoms) were manually bent to fit their density features. Segments
were shifted to align backbone hydrogen bonds, to allow interdigi-
tation of imagined sidechains, and to alleviate NCS collisions.
Comments on specific domains are given in Text S9.
Each ROSETTA-predicted domain chosen for the cpMVP model
contained a well-packed core structure, such as beta-sheets and helix,
usually with dangling N and C termini. The shapes of the core
features of each model were manually placed in electron-density
shapes, and were arranged subject to the restraint that the dangling
ends could later be manually reconnected to form a single covalent
cpMVP chain. The most extreme manual interventions to ROSETTA
models were applied to domain 2 (see Figure 5b and Text S9). Manual
intervention at some proline residues is discussed in Text S1.
The vertical stacking of domain models was usually clear from the
electron density and from the number of residues available for
connections. In the shoulder region of the cpMVP model, boundaries
between domains 8–11 are indistinct. The helix at the nominal
boundary between domains 9 and 10 (residues 494–503, bottom
foreground of Figure 5G) could be flipped left or right, resulting in
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shifting the top of the cpMVP model left or right relative to the
bottom of the model. The helix was flipped to its current location
because the flipped structure relieved strain in the backbone
geometry, and substantially increased contact area between domains
9 and 10 of the same MVP chain.
Energy minimization. Once the manually adjusted cpMVP model
was complete, its backbone geometry was brought nearer to expect-
ation values by torsion angle energy minimization using CNS [41],
which used a hydrogen-bonding energy term [42]. CNS added side
chain atoms. Some automatic rotamer choices were manually altered,
and some segments were manually shifted. After each round of
manual intervention in a refinement model segment, energy
minimization was performed on that segment maintaining covalent
connections at symmetry junctions (see Text S10). Model validation,
including a score based on the side chain atoms from CNS, is
discussed in Text S1.
Supporting Information
Figure S1. Two Maps Calculated with Pseudo-Babinet-Inverse Phase
Sets
The figure shows results of pseudo-Babinet-inverse phase condensa-
tions from two of the tests of averaging parameters leading to Figure
2. Appearance of recognizable structure (such as helix) will not
identify the true phase set at the low resolution of this analysis.
Instead, we judged plausibility of structures that would result in each
electron density map.
Found at doi:10.1371/journal.pbio.0050318.sg001 (47 KB PDF).
Figure S2. Cryoprotection-Annealing by Floating Microdialysis
The vault crystals were cryoprotected (and apparently annealed)
without osmotic shock by this microdialysis protocol.
Found at doi:10.1371/journal.pbio.0050318.sg002 (47 KB PDF).
Figure S3. Self-Rotation Function
The self-rotation function indicated the orientation of the vault in
the crystal.
Found at doi:10.1371/journal.pbio.0050318.sg003 (88 KB PDF).
Figure S4. Best Automated Molecular Replacement Result
Using cryo-EM electron density, initial phasing was attempted by
automated molecular replacement, but abandoned due to inaccuracy.
Found at doi:10.1371/journal.pbio.0050318.sg004 (63 KB PDF).
Figure S5. Manual Molecular Replacement
Initial reflection phases were calculated from the manually placed
and rotated cryo-EM electron density. The figure shows the main
steps of this placement.
Found at doi:10.1371/journal.pbio.0050318.sg005 (86 KB PDF).
Figure S6. Initial Packed Phasing Model
The half vault manually placed on a crystal 2-fold axis snugly packs
the cell. The figure shows a section through the packed cell and the
lack of phasing model for the N termini in the waist region of the
vault.
Found at doi:10.1371/journal.pbio.0050318.sg006 (63 KB PDF).
Model S1. Partially Assembled cpMVP Model
This partially-assembled cpMVP model is more convenient to
examine than the full model (Figure 6B). The file contains three
cpMVP dimers of the upper half vault, and N termini of the lower half
vault, with chain identifiers as defined within the file.
The file is compressed with gzip. Download uncompression tools
from http://www.gzip.org/. Some molecular viewer software options
for the PDB file format are listed at http://www.rcsb.org/pdb/.
Found at doi:10.1371/journal.pbio.0050318.sd001 (396 KB GZ).
Text S1. Validation of the cpMVP Model
Qualitative and quantitative validation is discussed.
Found at doi:10.1371/journal.pbio.0050318.sd002 (78 KB PDF).
Text S2. Details of Preparation and Crystallization of Vaults
Found at doi:10.1371/journal.pbio.0050318.sd003 (19 KB PDF).
Text S3. Anti-Vibration Platforms
This text lists suppliers, part numbers, and derivation of the part
numbers for the low-cost, vibration-damping platforms used under-
neath the most recent vault crystallizations.
Found at doi:10.1371/journal.pbio.0050318.sd004 (12 KB PDF).
Text S4. Protocol for Cryoprotection-Annealing of Vault Crystals by
Floating Microdialysis
Found at doi:10.1371/journal.pbio.0050318.sd005 (71 KB PDF).
Text S5. Details of Crystal Evaluation and Collection and Processing
of Diffraction Data
Found at doi:10.1371/journal.pbio.0050318.sd006 (54 KB PDF).
Text S6. Initial Phasing of x-Ray Reflections
Cryo-EM electron density was manually placed in the crystal cell to
initiate the phase set.
Found at doi:10.1371/journal.pbio.0050318.sd007 (14 KB PDF).
Text S7. Initial Density Modification
Reflection phases were improved by symmetry averaging and solvent
flattening, leading to the conclusion that MVP folds into domains.
Found at doi:10.1371/journal.pbio.0050318.sd008 (19 KB PDF).
Text S8. ‘‘Dot Model’’ Density Modification Phase Refinement
This text presents the detailed protocol used for further evolution of
the x-ray reflection phases and of the envelope around the vault.
Found at doi:10.1371/journal.pbio.0050318.sd009 (79 KB PDF).
Text S9. Domain-Specific Comments on cpMVP Model Building
Found at doi:10.1371/journal.pbio.0050318.sd010 (92 KB PDF).
Text S10. Details of Energy Minimization of the cpMVP Model
Found at doi:10.1371/journal.pbio.0050318.sd011 (11 KB PDF).
Accession Numbers
The 9-A˚ resolution cpMVP dimer model, the structure factors, and
the phases used to calculate electron density maps, have been
deposited in the Protein Data Bank [18,19] (http://www.rcsb.org/pdb)
with accession code 2QZV. The 96-mer vault nanocapsule (Figure 6B)
may be reconstructed from the cpMVP dimer using rotation matrices
contained in 2QZV, for example with graphics program CHIMERA
[43]. The NMR structure of domains 3 and 4 is entry 1Y7X [14]. For
convenience, a partially-assembled model is available as Model S1. We
again warn users of this model that its atom positions are
approximate.
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession
number for rat liver MVP sequence is Q62667.
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